::¼±ÅÃ::
2007
2008
2009
::¼±ÅÃ::
³í¹®¸í
ÃÊ·Ï
ÀúÀÚ¸í
Á¦ 3 ±Ç Á¦ 1È£ 2010
ÀǾàǰ¿ÀÇÁ¶óº§»ç¿ë°ú ±Ù°ÅÁß½ÉÀÇ»ç°áÁ¤ Off-label Drug Use and Its Implications for Evidence-based Decision Making
½ÅÁÖ¿µ1¤ýÁ¤¼±¿µ1¤ý¹Úº´ÁÖ1,2 Ju-Young Shin, MPH1, Sun-Young Jung, MSc1 and Byung-Joo Park, MD, PhD1
Off-label prescribing refers to the use of a drug for an indication which is not included in the approved labeling of the drug fr...
Á¦ 2 ±Ç Á¦ 1È£ 2009
¾à¹°°¨½Ã¿¬±¸»ç¾÷´Ü ÃßÁø¿¡ ÁîÀ½ÇÏ¿© About Pharmacovigilance Corporation
ÀÌÁøÈ£ Jin Ho Lee, MD, PhD
-
Á¦ 2 ±Ç Á¦ 2È£ 2009
¾à¹°°¨½Ã»ç¾÷´ÜÀÇ ¹ßÁ·°ú ¾à¹°¿ªÇÐÀ§Çذü¸®ÇÐȸÀÇ Âü¿© Inauguration of Pharmacovigilance Research Network and Collaboration with Korean Society for Pharmacoepidemiology and Risk Management
¹Úº´ÁÖ Byung Joo Park
-
Á¦ 1 ±Ç Á¦ 1È£ 2008
´ëÇѾ๰¿ªÇÐÀ§Çذü¸®ÇÐȸ ⸳ ÃëÁö Prospectus of the Korean Society for Pharmacoepidemiology and Risk Management
¹Úº´ÁÖ Byung-Joo Park, MD, PhD
-
1